The pharmaceutical industry is ready to fall off a cliff — a “patent cliff.” Over the next few years, some of the world’s most popular and lucrative medicines will go off patent, and generic competition will siphon an estimate…
If gasoline or jobs or milk were in short supply, we’d all know about it. But unknown to most Americans, the country is now in the grips of a life-threatening drug shortage. Medical professionals are quite aware of it, however,…
Companies have record amounts of cash to spend: $1.9 trillion. How can they put it to the best use to keep stock markets booming?
Continue reading How Companies Should Spend Their $1.9 Trillion in Cash
…
Unlike generics, which are the exact chemical copies of a brand-name drug, biosimilars have large and often complex proteins that are made in living cells, and tiny differences can play havoc with the product. It may take years…
Calling all investors: You’ll want to pay close attention in the days ahead. The mid-term elections, FOMC meeting, retail sales figures, an update on the labor market and more earnings from Toyota, Starbucks and more could set …